Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Lymphoma 173Lymphoma, Non-Hodgkin 155Leukemia, Lymphocytic, Chronic, B-Cell 154Lymphoma, Large B-Cell, Diffuse 134Lymphoma, Follicular 131Lymphoma, Mantle-Cell 93Leukemia 68Lymphoma, B-Cell, Marginal Zone 67Waldenstrom Macroglobulinemia 49Burkitt Lymphoma 43Lymphoma, B-Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Hodgkin Disease 36Recurrence 24Lymphoma, Large-Cell, Immunoblastic 24Neoplasms 15Myelodysplastic Syndromes 15Lymphoma, Large-Cell, Anaplastic 15Multiple Myeloma 13Leukemia, Myeloid, Acute 12Lymphoma, T-Cell, Cutaneous 9Lymphoma, Extranodal NK-T-Cell 9Leukemia, Hairy Cell 9Intraocular Lymphoma 9Hematologic Neoplasms 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Immunoblastic Lymphadenopathy 8Sezary Syndrome 7Mycosis Fungoides 7Lymphoma, T-Cell 7

Interventions

rozanolixizumab 5zilucoplan 4eculizumab 4efgartigimod alfa 3Rituximab 2Prednisone 2Amifampridine 2thymoglobulin 1satralizumab 1rhoA GTP-Binding Protein 1ravulizumab 1iscalimab 1inebilizumab 1gamma-Globulins 1Thymectomy 1Sugars 1Steroids 1Sodium Chloride 1Robotic Surgical Procedures 1Prednisolone 1Methylprednisolone 1Methotrexate 1Mesna 1Hizentra 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Fluid Therapy 1Cyclophosphamide 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Myasthenia Gravis × Rituximab × Clear all
NCT02950155 2024-10-26

Rinomax

Karolinska Institutet

Phase 3 Completed
47 enrolled 24 charts

Myasthenia Gravis

NCT02110706 2020-03-06

BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis

Yale University

Phase 2 Completed
52 enrolled 18 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡